Rheumatoid arthritis is a protective factor against Alzheimer’s disease: a bidirectional two-sample Mendelian randomization study
Authors:
- 27 December 2023
- journal article
- research article
- Published by Springer Nature in Inflammopharmacology
- Vol. 32 (1) , 863-871
Abstract
Background Epidemiological evidence suggests that there is an association between rheumatoid arthritis (RA) and Alzheimer’s disease (AD). However, the causal relationship between RA and AD remains unclear. Therefore, this study aimed to investigate the causal relationship between RA and AD. Methods Using publicly available genome-wide association study datasets, bidirectional two-sample Mendelian randomization (TSMR) was performed using the inverse-variance weighted (IVW), weighted median, MR‒Egger regression, simple mode, and weighted mode methods. Results The results of MR for the causal effect of RA on AD (IVW, odds ratio [OR] = 0.959, 95% confidence interval [CI]: 0.941–0.978, P = 2.752E-05; weighted median, OR = 0.960, 95% CI: 0.937–0.984, P = 0.001) revealed a causal association between genetic susceptibility to RA and an increased risk of AD. The results of MR for the causal effect of AD on RA (IVW, OR = 0.978, 95% CI: 0.906–1.056, P = 0.576; weighted median, OR = 0.966, 95% CI: 0.894–1.043, P = 0.382) indicated that there was no causal association between genetic susceptibility to AD and an increased risk of RA. Conclusions The results of this two-way two-sample Mendelian randomization analysis revealed a causal association between genetic susceptibility to RA and a reduced risk of AD but did not reveal a causal association between genetic susceptibility to AD and an increased or reduced risk of RA.Keywords
Funding Information
- the Natural Science Foundation of Gansu Province (20JR10RA358)
This publication has 60 references indexed in Scilit:
- Microglia: A new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease researchNeurobiology of Learning and Memory, 2013
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013
- The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functionsScientific Reports, 2012
- Avoiding bias from weak instruments in Mendelian randomization studiesInternational Journal of Epidemiology, 2011
- Resting Microglia Directly Monitor the Functional State of SynapsesIn Vivoand Determine the Fate of Ischemic TerminalsThe Journal of Neuroscience, 2009
- A Neuroprotective Function for the Hematopoietic Protein Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)Journal of Cerebral Blood Flow & Metabolism, 2007
- Effect of NSAIDs on risk of Alzheimer's diseaseBMJ, 2003
- Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidenceNeurobiology of Aging, 2001
- Inverse association of anti‐inflammatory treatments and Alzheimer's diseaseNeurology, 1994
- Anti-inflammatory drugs and Alzheimer diseaseThe Lancet, 1990